Nestle stock edges lower after USD 1 billion vitamins sale

Nestle stock (CH0038863350) is trading modestly lower around 77.80 Swiss francs as of September 2, 2026, on the SIX Swiss Exchange after the group agreed to sell its mainstream vitamins, minerals and supplements business to private equity firm Yellow Wood Partners for USD 1 billion, while the broader SMI index is also slightly in the red according to market data from Cboe Europe and Swiss media reports.

USD 1 billion vitamins divestment reshapes portfolio

According to a report by Reuters dated September 1, 2026, Nestle has agreed to sell its mainstream vitamins, minerals and supplements business to Yellow Wood Partners for USD 1 billion, as CEO Philipp Navratil continues to narrow the company’s focus on areas where it has the strongest competitive advantage. The package includes seven brands such as Nature Bounty, Osteo Bi-Flex, Ester-C, Gard, Nuun, Puritan Pride and Sisu as well as a US private-label supplements operation, which together generated USD 1.2 billion in sales in 2025. That implies the divested unit is being sold at roughly 0.83 times its 2025 sales, highlighting that Nestle prioritizes strategic fit and deleveraging over maximizing the revenue multiple.

A separate article from Swissinfo published on September 2, 2026, notes that the mainstream vitamins business is predominantly US-focused and generated USD 1.2 billion in sales in 2025, confirming the scale of the operations being sold. The same report highlights that the proceeds are earmarked to reduce leverage, potentially creating room for future acquisitions once balance sheet metrics move into management’s targeted range. For investors, this means the vitamins sale not only simplifies the portfolio but also frees up financial capacity that could be redeployed into core categories like coffee, petcare and food and snacks.

Analysts see moderate upside as stock lags SMI highs

Market data compiled by European financial portals on September 2, 2026, show Nestle stock trading around 77.80 to 77.90 Swiss francs in intraday action, down about 0.8 percent compared with the prior closing price of 78.51 Swiss francs. Over the past five trading days, the shares have slipped roughly 0.8 percent, while the SMI index has also eased, indicating that the latest move is part of a broader market softness rather than an isolated sell-off in Nestle.

An analysis summarized by MarketScreener on September 2, 2026, cites a consensus target price of 88.36 Swiss francs for Nestle, compared with the recent close of 78.51 Swiss francs. This implies potential upside of around 12.5 percent if the stock were to reach the average target, suggesting that analysts expect some re-rating as portfolio measures and margin initiatives bear fruit. Another note reported by the same portal indicates that a major Swiss bank maintains a Neutral rating with a specific target of 80 Swiss francs, which represents a modest premium of about 1.9 Swiss francs, or roughly 2.4 percent, relative to the prior closing price, underscoring that expectations in the DACH banking community remain cautious in the short term.

For DACH-based investors, it is notable that Nestle is a heavyweight in the SMI, and the stock’s recent level around 77.80 Swiss francs leaves it below its previous 2022 highs, as Swissinfo points out, even after a partial recovery over the past year. From a valuation perspective, the gap between the current price and the 88.36 Swiss franc consensus target provides a quantified comparison: the market is currently discounting the stock by about one-eighth relative to average analyst expectations, reflecting lingering concerns about growth momentum and execution despite ongoing portfolio optimization.

Core categories and product focus after the sale

Swissinfo’s coverage on September 2, 2026, emphasizes that the sale of the mainstream vitamins unit is part of a broader strategy to refocus on Nestle’s strongest pillars, including coffee, petcare and food and snacks. In particular, the company has already taken steps earlier in 2026 to spin off parts of its water business into a joint venture and is also working on divesting its ice cream interests, signaling a clear shift toward categories where it sees higher growth and margin potential. Management has indicated that the divestment frees up management time and operational resources, allowing teams to concentrate on priority areas where Nestle believes it has a higher competitive edge.

A key example of this product focus is Nestle’s flagship Nescafe coffee brand, which remains one of the company’s largest contributors within beverages. By concentrating investments and innovation around Nescafe and other leading brands, Nestle aims to improve organic sales growth and enhance profitability in categories where brand strength and scale enable pricing power. At the same time, the company plans to retain premium vitamins and supplements brands such as Solgar and Pure Encapsulations, underlining that the exit is limited to mainstream segments and not a complete withdrawal from the broader health and wellness space.

Stock valuation and investor perspective

As of September 2, 2026, Nestle stock’s recent trading level of around 77.80 Swiss francs compares with the last closing price of 78.51 Swiss francs and a consensus target of 88.36 Swiss francs, leaving a quantified valuation gap of about 12.5 percent. This spread between the market price and average analyst expectations indicates that investors currently price in execution risks and macro headwinds, but also leave room for potential upside if the portfolio reshaping and margin initiatives deliver. For many investors, the question is whether the USD 1 billion divestment and associated deleveraging can accelerate earnings growth enough to justify a re-rating toward the consensus target.

In addition, the vitamins unit’s 2025 sales of USD 1.2 billion compared with the USD 1 billion transaction value highlight that Nestle is accepting a sale multiple below one time sales to streamline its portfolio and focus on core categories. Historically, the company paid USD 5.75 billion in 2021 to acquire many of these brands, so the current divestment marks a shift from acquisition-driven expansion to disciplined portfolio pruning. For long-term holders of Nestle stock, this evolution underscores a strategy centered on sharpening competitive advantages rather than simply accumulating assets.